Endurance Trial: Ketone and Carbohydrate Supplementation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age20-50
SponsorUniversity of Sao Paulo

About this trial

This randomized, double-blind, crossover study investigates the effects of exogenous ketone supplementation on physical and cognitive performance in amateur endurance athletes during exhaustive exercise. Participants will complete three 3-hour cycling sessions under different nutritional conditions: carbohydrate alone (CHO), carbohydrate plus ketone (CHO-KET), and placebo (PLA). The study will assess cognitive function through validated computerized tests, physical performance via distance covered, and metabolic responses through blood biomarkers. Additionally, peripheral blood mononuclear cells (PBMCs) will be collected and cultured with LPS or not. Other PBMCs co-cultured with neuronal cells (SH-SY5Y) to investigate neuro-immune interactions. The primary hypothesis is that ketone supplementation will preserve cognitive function and enhance physical performance during prolonged exhaustive exercise compared to carbohydrate supplementation alone, potentially through anti-inflammatory mechanisms and alternative energy substrate provision.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Amateur male cyclists;

At least 2 years of cycling experience;

At least 5 hours of endurance cycling training per week;

VO2max of at least 50 mL/kg/min.

Disqualifiers

Confirmed diagnosis of COVID-19 by PCR or rapid antigen test within the last 12 months;

Symptoms compatible with COVID-19 within the last six months;

Smokers;

Alcoholics;

Trial design

Design model

Crossover

Treatments tested in this trial

  • Carbohydrate beverage

    Dietary supplement

    Participants ingest 210 mL of a \~15% carbohydrate solution, providing 30 g of carbohydrate per dose, every 20 minutes from the start of the 155-minute fixed-intensity phase, with the final dose taken immediately before the start of the 20-minute maximal effort block. No beverage is provided during the maximal effort. The solution combines sucrose and dextrose so that glucose and fructose are absorbed through separate intestinal transporters. All doses are supplied in opaque, coded bottles prepared by a researcher not involved in the assessments, so that treatments cannot be identified visually.

  • (R)-1,3-butanediol

    Dietary supplement

    Participants ingest (R)-1,3-butanediol at 1.0 g/kg body mass 45 minutes before the start of the cycling protocol and a further 0.5 g/kg 5 minutes before the start, for a total dose of 1.5 g/kg body mass. The dose was selected to sustain blood beta-hydroxybutyrate at approximately 2 mmol/L throughout the session, a range compatible with nutritional ketosis and without risk to participants. Doses are supplied in opaque, coded bottles prepared by a researcher not involved in the assessments.

  • Pre-exercise non-caloric placebo

    Dietary supplement

    Participants ingest a non-caloric placebo beverage at 45 and 5 minutes before the start of the cycling protocol, at the same time points at which the (R)-1,3-butanediol is administered in the CHO-KET arm. The placebo is matched to the ketone beverage for volume, appearance and flavour, and provides no energy. Doses are supplied in opaque, coded bottles prepared by a researcher not involved in the assessments.

  • During-exercise non-caloric placebo

    Dietary supplement

    Participants ingest 210 mL of a non-caloric placebo beverage every 20 minutes from the start of the 155-minute fixed-intensity phase, with the final dose taken immediately before the start of the 20-minute maximal effort block. No beverage is provided during the maximal effort. The placebo is water with the same flavouring used in the carbohydrate beverage, matched for volume, appearance and ingestion schedule, and provides no energy. Doses are supplied in opaque, coded bottles prepared by a researcher not involved in the assessments.

  • Standardized evening meal

    Other intervention

    On the evening before each experimental session, participants consume a standardized meal providing 1.5 g of carbohydrate per kg of body mass. The same meal is provided before all three experimental sessions and is followed by an overnight fast of 8 to 12 hours.

  • Prolonged cycling exercise protocol

    Other intervention

    Each experimental session comprises 5 minutes of warm-up at 100 W, 155 minutes at 55% of maximal power output (Wmax) with the cycle ergometer set in hyperbolic mode, and a final 20 minutes of maximal self-paced effort in linear mode, followed by 5 minutes of low-load cool-down. The same protocol is applied in all three conditions, with load individually prescribed from the maximal incremental test performed at the pre-experimental visit.

  • Standardized breakfast

    Other intervention

    On the morning of each experimental session, after the baseline venous blood draw and following an overnight fast of 8 to 12 hours, participants consume a standardized breakfast providing 1.5 g of carbohydrate per kg of body mass, 40 g of protein and 7 g of fat. Participants are instructed to consume the entire meal. The same breakfast is provided before all three experimental sessions.

Treatment groups

12 Participants
are divided into 3 treatment groups
Group A: Carbohydrate (CHO)Active comparator 5 interventions
Group B: Placebo (PLA)Placebo comparator 5 interventions
Group C: Carbohydrate plus ketone (CHO-KET)Experimental treatment 5 interventions

Trial outcomes

Primary outcomes

1

Distance covered during the final 20 minutes of maximal effort

Physical performance is assessed as the distance covered during the final 20-minute maximal effort block of each experimental session. Each session begins with 5 minutes of warm-up at 100 W, followed by 155 minutes at 55% of maximal power output (Wmax) with the cycle ergometer set in hyperbolic mode, and ends with 20 minutes of maximal self-paced effort in linear mode. Load is individually prescribed from the maximal incremental test performed at Visit 1. Participants ride the bicycle they are accustomed to, mounted on an electromagnetically braked cycle ergometer, and distance is recorded by the ergometer software. Unit: kilometres

Time frame
Visits 2, 3 and 4 (weeks 3, 4 and 5): final 20 minutes of exercise.
2

Visuospatial working memory: Corsi block-tapping span

Visuospatial working memory is assessed with the Corsi block-tapping task from the Psychology Experiment Building Language (PEBL) battery. Sequences of illuminated squares are presented, starting with two blocks and increasing by one every two attempts, until two consecutive errors occur. The span is the length of the longest sequence correctly reproduced; higher values indicate better working memory. Participants are familiarized with the task at Visit 1, and a brief rehearsal is performed immediately before testing at each experimental session. Unit: number of blocks

Time frame
Visit 1 (week 0), familiarization session. Visits 2, 3 and 4 (weeks 3, 4 and 5): 15 minutes after the standardized breakfast, before the first supplement dose; and 5 minutes after the end of exercise.
3

Inhibitory control: accuracy on No-Go trials

Inhibitory control is assessed with the Go/No-Go task from the PEBL battery. The letters P or R replace a blue star on screen, with 10 practice trials followed by 160 stimuli per block in an 80:20 Go to No-Go ratio, a 500-millisecond stimulus duration and a 1500-millisecond inter-stimulus interval. Accuracy on No-Go trials is reported as the proportion of correctly withheld responses, ranging from 0 to 1, with higher values indicating better inhibitory control. Unit: proportion of correct responses

Time frame
Visit 1 (week 0), familiarization session. Visits 2, 3 and 4 (weeks 3, 4 and 5): 15 minutes after the standardized breakfast, before the first supplement dose; and 5 minutes after the end of exercise.
4

Processing speed: reaction time on Go trials

Reaction time on correct Go trials of the Go/No-Go task described above is recorded automatically by the PEBL software and reported as the mean latency in milliseconds. Lower values indicate faster processing speed.

Time frame
Visit 1 (week 0), familiarization session. Visits 2, 3 and 4 (weeks 3, 4 and 5): 15 minutes after the standardized breakfast, before the first supplement dose; and 5 minutes after the end of exercise.

Secondary outcomes

1

Gastrointestinal symptom severity

A 10-point Likert-type scale, adapted into a 20 cm visual analogue scale, is used, where 0 indicates absence of symptoms and 10 indicates extreme symptoms, so that higher scores indicate worse tolerance. The questionnaire comprises three sections: upper abdominal symptoms (reflux, abdominal distension, nausea, vomiting); lower abdominal symptoms (cramps, flatulence, abdominal pain, diarrhoea); and systemic symptoms (dizziness, headache, muscle cramps). Unit: score on a 0 to 10 scale

Time frame
Visits 2, 3 and 4 (weeks 3, 4 and 5): immediately before breakfast; immediately before exercise; 40, 100 and 160 minutes after exercise onset; immediately after exercise; and 60 minutes after exercise.
2

Serum intestinal fatty acid-binding protein concentration

Serum concentration of intestinal fatty acid-binding protein (I-FABP) is quantified by enzyme-linked immunosorbent assay (HK406, Hycult Biotech, Uden, Netherlands). Samples are analysed in duplicate according to the manufacturer's instructions on the same day, with standards and controls on each plate, and all samples from a given participant are assayed on the same plate to minimize inter-assay variability. Unit: picograms per millilitre

Time frame
Visits 2, 3 and 4 (weeks 3, 4 and 5): baseline on arrival after an 8 to 12 hour overnight fast, and 60 minutes after the end of exercise.
3

Protein expression of kynurenine pathway, endoplasmic reticulum stress, autophagy and oxidative stress markers in PBMCs

Peripheral blood mononuclear cells are isolated from whole blood by Ficoll-Hypaque density-gradient centrifugation. Total protein is extracted with RIPA buffer containing protease inhibitors and quantified by the bicinchoninic acid assay. Protein expression of enzymes of the kynurenine pathway and of markers of endoplasmic reticulum stress, autophagic flux and oxidative stress is determined by Western blot after SDS-PAGE separation, transfer to nitrocellulose membrane, overnight incubation with specific primary antibodies, incubation with a peroxidase-conjugated secondary antibody, chemiluminescent detection and densitometric analysis. Unit: arbitrary units, normalized to loading control

Time frame
Visits 2, 3 and 4 (weeks 3, 4 and 5): baseline on arrival after an 8 to 12 hour overnight fasting, and 60 minutes after the end of exercise.
4

Sleep difficulty score on the Athlete Sleep Screening Questionnaire

Sleep is assessed with the Athlete Sleep Screening Questionnaire (ASSQ), validated for Brazilian athletes. The instrument comprises 15 items covering sleep quantity, sleep quality, insomnia and chronotype; only the first seven items are used, as these generate the sleep difficulty score (SDS). The SDS ranges from 0 to 17, with higher scores indicating greater sleep difficulty, and classifies athletes into four categories of clinical sleep problems: none (0 to 4), mild (5 to 7), moderate (8 to 10) and severe (11 to 17). The questionnaire refers to the 7 days preceding its administration. Because the three experimental sessions are separated by a one-week washout, each administration characterizes sleep during the week that precedes the corresponding condition. Unit: score on a scale

Time frame
Sleep during the 7 days preceding each assessment. Assessed at Visit 1 (week 0) and at Visits 2, 3 and 4 (weeks 3, 4 and 5). At the experimental sessions the questionnaire is administered immediately after the standardized breakfast.

Other outcomes

1

Total work produced during the final 20 minutes of maximal effort

Total mechanical work produced during the final 20-minute maximal effort block, calculated from power output recorded continuously by the cycle ergometer. Unit: kilojoules

Time frame
Visits 2, 3 and 4 (weeks 3, 4 and 5): final 20 minutes of exercise.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.